Skip to main content
Back
Watch Compare

VYCOR MEDICAL INC

Data quality: 100%
VYCO
OTC Manufacturing Measuring & Analyzing Instruments
$0.07
$0.00 (0.00%)
6 months return
—
Momentum
Neutral
5Y revenue growth
7.54%

Growth

Revenue Growth (5Y)
7.54%
Above sector avg (1.92%)
Revenue (1Y)17.24%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROICN/A
Net Margin-3.89%
Op. Margin1.82%

Safety

Debt / Equity
N/A
Current Ratio0.14
Interest Coverage2.57

Valuation

PE (TTM)
-44.70
Below sector avg (-1.50)
P/B RatioN/A
EV/EBITDA33.96
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Revenue grew 7.54% annually over 5 years — modest growth
Negative free cash flow of -18,695.0
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 9.70%
Capital efficient — spends only 0.28% of revenue on capex

Price History

Financial Trends

Analyst Price Target

No analyst coverage available

Growth

Rev 5Y: 7.54% · Earnings 1Y: N/A
Revenue Growth (1Y) 17.24% Revenue Growth (3Y) 12.95%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 7.54% Earnings Growth (5Y) N/A

Profitability

ROE: N/A · Net Margin: -3.89%
Revenue (TTM) 1.86 M Net Income (TTM) -72,426.0
ROE N/A ROA -7.96%
Gross Margin 83.78% Operating Margin 1.82%
Net Margin -3.89% Free Cash Flow (TTM) -18,695.0
ROIC N/A FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 0.14
Debt / Equity N/A Current Ratio 0.14
Interest Coverage 2.57 Asset Turnover 2.05
Working Capital -4.15 M Tangible Book Value -4.02 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -44.70 · EV/EBITDA: 33.96
P/E Ratio -44.70 Forward P/E N/A
P/B Ratio N/A P/S Ratio 1.74
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 33.96 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -0.58%
Market Cap 3.24 M Enterprise Value 3.17 M

Per Share

EPS: -0.01 · FCF/Share: 0.00
EPS (Diluted TTM) -0.01 Revenue / Share 0.06
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 25.81% · CapEx/Rev: 0.28%
CapEx / Revenue 0.28% FCF Conversion 25.81%
SBC-Adj. FCF -73,638 Growth Momentum 9.70

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.86 M 1.59 M 1.46 M 1.22 M 1.39 M
Net Income -72,426.0 -107,200.0 -69,691.0 -404,917.0 -435,662.0
EPS (Diluted) -0.01 -0.01 -0.01 — —
Gross Profit 1.56 M 1.42 M 1.32 M 1.08 M 1.26 M
Operating Income 33,900.0 -9,145.0 40,191.0 -306,514.0 -435,954.0
EBITDA — — — — —
R&D Expenses 9,963.0 15,325.0 22,558.0 15,159.0 15,159.0
SG&A Expenses 1.46 M 1.36 M 1.20 M 1.33 M 1.61 M
D&A 59,521.0 59,521.0 57,497.0 58,232.0 66,070.0
Interest Expense 13,200.0 13,200.0 13,200.0 13,200.0 13,200.0
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 830,420.0 998,117.0 992,298.0 860,178.0 935,364.0
Total Liabilities 4.92 M 4.69 M 4.32 M 3.80 M 3.33 M
Shareholders' Equity -4.09 M -3.69 M -3.33 M -2.94 M -2.40 M
Total Debt — — — — 150,000.0
Cash & Equivalents 86,982.0 105,648.0 57,291.0 37,035.0 90,941.0
Current Assets 563,422.0 695,719.0 584,090.0 517,763.0 487,411.0
Current Liabilities 4.78 M 4.50 M 4.07 M 3.65 M 3.15 M

Peer Comparison

vs Manufacturing sector median (1605 peers)
Metric Stock Sector Median
P/E -44.7 -1.5
P/B — 1.6
ROE % — -54.5
Net Margin % -3.9 -41.5
Rev Growth 5Y % 7.5 1.9
D/E — 0.3